Press releases

Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference

Read This Press Release

Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases

Read This Press Release

Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy

Read This Press Release

Scholar Rock to Present at the BMO 2018 Prescriptions for Success Healthcare Conference

Read This Press Release

Scholar Rock Announces Publication of Preclinical Data on the Therapeutic Benefit of Inhibiting Myostatin Activation in Models of Spinal Muscular Atrophy

Read This Press Release

Scholar Rock Announces the Addition of Edward (Ted) Myles to Its Board of Directors

Read This Press Release

Scholar Rock Demonstrates that Highly Specific TGFβ1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade Therapy

Read This Press Release

Scholar Rock Reports Third Quarter 2018 Financial Results and Highlights Business Progress

Read This Press Release